TrialLeukemia & lymphoma2013
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.
Lakshmi Nayak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papertrialcites it